The Business Research Company’s report on the Rabies Diagnostics Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
Which emerging drivers are set to accelerate the growth of the rabies diagnostics market further?
The increasing prevalence of rabies is expected to propel the growth of the market for rabies diagnostics. Rabies is a preventable viral illness that is most commonly spread via a rabid animal’s bite. The rabies virus attacks mammals’ central nervous systems, eventually causing brain damage and leading to death. Rabies diagnosis is used to detect the rabies virus in humans and animals using a variety of diagnostic tests and techniques. Additionally, the rising cases of infectious animal-transmitted diseases have favored the demand for rabies diagnostics. For instance, in January 2023, according to the report published by the Government of Canada, a Canada-based federal authority, there were 135 rabies samples submitted in October 2022 and 159 rabies samples submitted in November 2022. Therefore, the increasing prevalence of rabies will drive the rabies diagnostics market.
Access Your Free Sample of the Global Rabies Diagnostics Market Report – Get Insights Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=8476&type=smp
What are the key factors influencing the forecasted market size of the rabies diagnostics industry?
The rabies diagnostics market size has grown strongly in recent years. It will grow from $1.68 billion in 2024 to $1.78 billion in 2025 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to globalization and travel patterns, one health approach adoption, regulatory standards development, advancements in animal testing, environmental influences.
The rabies diagnostics market size is expected to see strong growth in the next few years. It will grow to $2.31 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to increasing rabies incidence, environmental impact, cost efficiency, research and development, surveillance needs. Major trends in the forecast period include government initiatives and vaccination programs, globalization and travel, one health approach, public health concerns, remote and point-of-care diagnostics.
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=8476&type=smp
Who are the leading competitors in the rabies diagnostics market?
Major companies operating in the rabies diagnostics market are Bio-Rad Laboratories Inc., The Merck Group, Aviva Systems Biology Corporation, Creative Diagnostics, Demeditec Diagnostics GmbH, Abbexa Ltd., Norgen Biotek Corp., BioNote Inc., Express Biotech International Inc., MyBioSource Inc., QIAGEN N.V., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Agilent Technologies Inc., Fluidigm Corp., Bio-X Diagnostics S.A., Fujirebio Diagnostics Inc., Gold Standard Diagnostics Corp., Heska Corporation, IDEXX Laboratories Inc., InBios International Inc., KHB Shanghai Kehua Bio-Engineering Co. Ltd., Meridian Bioscience Inc., MP Biomedicals LLC, Neogen Corporation, Randox Laboratories Ltd., SDIX LLC, Sigma-Aldrich Corporation, Virbac Animal health Pvt. Ltd., Zoetis Inc.
Which emerging trends are set to transform the rabies diagnostics market landscape?
Product innovation has emerged as a key trend gaining popularity in the rabies diagnostics market. Innovation and development of efficient testing techniques in the field of analytical chemistry designed to provide accurate and cost-effective analytical solutions are being adopted by pharmaceutical manufacturers all around the globe. These testing products are efficiently integrated into the regular sample testing process. For instance, in May 2022, Bio-Rad Laboratories Inc., a US-based developer, and manufacturer of specialized technology products launched the CFX Duet Real-Time PCR system, a clinical diagnostic device designed to aid researchers in the development of singleplex and duplex quantitative PCR (qPCR) tests. The unique features of the product provide improved thermal performance, as well as a patented, precise optical shuttle system and thermal gradient functionality for optimization.
How do different geographies compare in terms of market share and growth potential in the rabies diagnostics market?
North America was the largest region in the rabies diagnostics market in 2024. The regions covered in the rabies diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Order Your Report Now For Swift Delivery
https://www.thebusinessresearchcompany.com/report/rabies-diagnostics-global-market-report
Which major segments of the rabies diagnostics market are experiencing the fastest growth?
The rabies diagnostics market covered in this report is segmented –
1) By Diagnostic Method: Fluorescent Antibody Test, Immunohistochemical Test, Amplification Methods, Histologic Examination, Serology Tests
2) By Technology: ELISA Or Immunohistochemistry, Chromatography Techniques, PCR, Other Technologies
3) By End-User: Hospital, Diagnostic Centers, Cancer Palliative Care Clinics, Other End-Users
Subsegments:
1) By Fluorescent Antibody Test: Direct Fluorescent Antibody Test (DFA)
2) By Immunohistochemical: Enzyme-Linked Immunosorbent Assay (ELISA): Western Blotting
3) By Amplification Methods: Polymerase Chain Reaction (PCR), Reverse Transcription PCR (RT-PCR)
4) By Histologic Examination: Microscopic Examination, Tissue Staining Techniques
5) By Serology Tests: Virus Neutralization Test (VNT), Enzyme-Linked Immunosorbent Assay (ELISA)
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8476
How is the rabies diagnostics market defined?
Rabies diagnostics refers to the process of identifying Rabies disease based on the condition and symptoms. It is a preventable viral illness that is most commonly spread via a rabid animal’s bite. Rabies can be diagnosed once the rabies virus is found in any portion of the infected animal’s brain. In humans, saliva, serum, spinal fluid, and skin biopsies of hair follicles at the nape of the neck are tested for diagnosis.
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
